IRLAB THERAPEUTICS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.7 SEK | +3.01% |
|
-1.44% | +82.00% |
| 05-27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
| 05-27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IRLAB THERAPEUTICS AB | Other Pharmaceuticals | +3.01% | -1.44% | +82.00% | +77.27% | -84.73% | 65.6M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
- Comparison Chart
